Antibiotic Use Rises in Luxembourg Since 2021

Antibiotic consumption in Luxembourg has risen steadily since 2021, according to health data, prompting concern among medical experts about the country's prescribing habits.

The figures show that Luxembourg now uses more antibiotics per capita than its European neighbours, placing it ahead of several comparable countries in the region.

This development comes amid growing international concern over antibiotic resistance, a phenomenon in which bacteria evolve to survive exposure to drugs that would normally kill them or stop their growth.

Experts warn that overuse and misuse of antibiotics are among the main drivers of resistance, which can render common infections much harder, and sometimes impossible, to treat effectively.

The World Health Organization has repeatedly identified antibiotic resistance as one of the biggest threats to global public health, urging countries to monitor and reduce unnecessary prescriptions.

In Luxembourg, health authorities are expected to examine the reasons behind the upward trend, which may include patient demand, prescribing practices, or seasonal patterns of illness.

Public health officials typically recommend that antibiotics be reserved for bacterial infections, since the drugs are ineffective against viral illnesses such as colds and influenza.

Several European countries have launched campaigns encouraging responsible use of antibiotics, including stricter prescription guidelines and public education efforts aimed at reducing demand for the drugs when they are not medically necessary.

Whether Luxembourg will adopt similar measures remains to be seen, but the latest figures are likely to intensify pressure on policymakers to address the issue.

Observers note that comparing antibiotic use across countries can help identify best practices, as nations with lower consumption often have stricter regulations or more robust public awareness programmes.

The situation in Luxembourg reflects a broader European challenge, as health systems across the continent grapple with balancing effective treatment of infections against the long-term risks posed by antibiotic resistance.